In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate

The emergence and rapid spread of the Omicron variant of SARS-CoV-2, which has more than 30 substitutions in the spike glycoprotein, compromises the efficacy of currently available vaccines and therapeutic antibodies. Using a clinical strain of the Omicron variant, we analyzed the neutralizing power...

Descripción completa

Detalles Bibliográficos
Autores principales: Touret, Franck, Baronti, Cécile, Bouzidi, Hawa Sophia, de Lamballerie, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931583/
https://www.ncbi.nlm.nih.gov/pubmed/35304531
http://dx.doi.org/10.1038/s41598-022-08559-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931583/
https://www.ncbi.nlm.nih.gov/pubmed/35304531
http://dx.doi.org/10.1038/s41598-022-08559-5

Ejemplares similares